Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Michael

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
JAMA|April 18, 1998
Protective effect of an SDF-1 variant in HIV disease: abstract and commentaryN L Michael
Current Opinion in Immunology|August 17, 1999
Host genetic influences on HIV-1 pathogenesisN L Michael
Methods in Molecular Medicine|March 8, 2011
Determination of the Promoter Activity of HIV-1 Using the Chloramphenicol Acetyltransferase Reporter Gene AssayL Tse, N L Michael
Nature Medicine|July 8, 1999
HIV-1 entry inhibitors: evading the issueN L Michael, J P Moore
Nature Medicine|December 2, 1999
Viral phenotype and CCR5 genotypeN L Michael, J P Moore
Dermatologic Clinics|July 1, 1991
Natural history of human immunodeficiency virus infectionN L Michael, D S Burke
Journal of Human Virology|November 6, 2001
Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1R A McDonald, G Chang, N L Michael
Lancet (London, England)|September 18, 1997
CCR5-delta 32 gene deletion in HIV-1 infected patientsN L Michael, L G Louie, H W Sheppard
Tropical Diseases, Travel Medicine and Vaccines|September 9, 2017
Prospecting for an HIV vaccineD M Brett-Major, T A Crowell, N L Michael
Journal of Virology|May 1, 1994
Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activitiesN L Michael, L D'Arcy, P K Ehrenberg, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
JAMA|April 18, 1998
Protective effect of an SDF-1 variant in HIV disease: abstract and commentaryN L Michael
Current Opinion in Immunology|August 17, 1999
Host genetic influences on HIV-1 pathogenesisN L Michael
Methods in Molecular Medicine|March 8, 2011
Determination of the Promoter Activity of HIV-1 Using the Chloramphenicol Acetyltransferase Reporter Gene AssayL Tse, N L Michael
Nature Medicine|July 8, 1999
HIV-1 entry inhibitors: evading the issueN L Michael, J P Moore
Nature Medicine|December 2, 1999
Viral phenotype and CCR5 genotypeN L Michael, J P Moore
Dermatologic Clinics|July 1, 1991
Natural history of human immunodeficiency virus infectionN L Michael, D S Burke
Journal of Human Virology|November 6, 2001
Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1R A McDonald, G Chang, N L Michael
Lancet (London, England)|September 18, 1997
CCR5-delta 32 gene deletion in HIV-1 infected patientsN L Michael, L G Louie, H W Sheppard
Tropical Diseases, Travel Medicine and Vaccines|September 9, 2017
Prospecting for an HIV vaccineD M Brett-Major, T A Crowell, N L Michael
Journal of Virology|May 1, 1994
Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activitiesN L Michael, L D'Arcy, P K Ehrenberg, et al.
Pageof 6